From: Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation
Variables | AF patients (n = 706) | Controls (n = 661) | P |
---|---|---|---|
Echocardiography results | Â | Â | Â |
LAD, mm | 40.23 ± 8.40 | 31.34 ± 4.63 | < 0.001 |
LVDd, mm | 46.82 ± 8.44 | 43.95 ± 5.75 | < 0.001 |
LVSd, mm | 33.85 ± 9.17 | 29.44 ± 6.03 | < 0.001 |
LVEF, % | 54.13 ± 12.84 | 62.20 ± 8.37 | < 0.001 |
Laboratory data | Â | Â | Â |
TC ≥ 5.2mmol/L, n (%) | 178(18.13) | 48(7.26) | < 0.001 |
TG ≥ 1.7mmol/L, n (%) | 167(23.65) | 96(14.52) | < 0.001 |
HDL-C < 1mmol/L, n (%) | 191(27.05) | 166(25.11) | 0.414 |
LDL-C ≥ 3.4mmol/L, n (%) | 109(15.44) | 18(2.72) | < 0.001 |
Apo-A1 ≥ 1.6 g/L, n (%) | 38(5.38) | 48(7.26) | 0.153 |
Apo-B ≥ 1.1 g/L, n (%) | 99(14.02) | 26(3.93) | < 0.001 |
ALT, U/L | 32.42 ± 25.54 | 26.80 ± 20.05 | < 0.001 |
AST, U/L | 42.49 ± 43.66 | 29.83 ± 27.88 | < 0.001 |
UN, mmol/L | 8.24 ± 5.06 | 6.46 ± 3.30 | < 0.001 |
Scr, umol/L | 125.70 ± 85.70 | 102.51 ± 70.39 | < 0.001 |
UA, umol/L | 412.45 ± 145.89 | 325.74 ± 110.82 | < 0.001 |
CRP, mg/L | 46.59 ± 57.46 | 41.81 ± 46.65 | 0.302 |
WBC, 109/L | 9.53 ± 4.55 | 9.04 ± 4.44 | 0.563 |